Share on StockTwits

CombiMatrix (NASDAQ:CBMX) CFO Scott R. Burell acquired 1,000 shares of CombiMatrix stock in a transaction that occurred on Wednesday, August 27th. The stock was purchased at an average cost of $2.04 per share, with a total value of $2,040.00. Following the completion of the purchase, the chief financial officer now directly owns 1,912 shares of the company’s stock, valued at approximately $3,900. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of CombiMatrix (NASDAQ:CBMX) traded down 3.90% during mid-day trading on Thursday, hitting $1.97. The stock had a trading volume of 167,793 shares. CombiMatrix has a 52-week low of $1.91 and a 52-week high of $4.44. The stock has a 50-day moving average of $2.16 and a 200-day moving average of $2.49. The company’s market cap is $21.8 million.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of CombiMatrix in a research note on Friday, August 8th. They now have a $3.50 price target on the stock.

CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc located in Irvine, California.

Receive News & Ratings for CombiMatrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CombiMatrix and related companies with Analyst Ratings Network's FREE daily email newsletter.